Atea Pharmaceuticals, Inc. (AVIR) vs MapLight Therapeutics, Inc. (MPLT)

A side-by-side comparison of Atea Pharmaceuticals, Inc. and MapLight Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Atea Pharmaceuticals, Inc. logo
AVIR
Atea Pharmaceuticals, Inc.
$415M
$5.19HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT
MapLight Therapeutics, Inc. logo
MPLT
MapLight Therapeutics, Inc.
$399M
$9.40HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT

Total return — AVIR vs MPLT

growth of $100 · dividends reinvested · last 1y
AVIR +57.8% (+57.8%/yr)MPLT -49.4% (-49.4%/yr)AVIR compounded faster over this window
50100150200Start $1002026$158$51
AVIR MPLT

AVIR vs MPLT: by the numbers

  • •AVIR is the larger company ($415M vs $399M market cap).

Metrics side by side

Valuation

MetricAVIRMPLT
P/B ratio2.031.14

Profitability

MetricAVIRMPLT
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-80.96%-65.99%
ROIC-89.93%-69.35%

Growth (annualized)

MetricAVIRMPLT
Total return CAGR (5Y)-34.44%N/A

Go deeper

Full AVIR analysisFull MPLT analysisInteractive comparison tool

Dig into the metrics

Atea Pharmaceuticals ROEMapLight Therapeutics ROEAtea Pharmaceuticals operating marginMapLight Therapeutics operating marginAtea Pharmaceuticals revenue growthMapLight Therapeutics revenue growthAtea Pharmaceuticals free cash flowMapLight Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.